New Nicotine Alliance welcomes smoking and health action report

Sep.02.2022
New Nicotine Alliance welcomes smoking and health action report
New Nicotine Alliance welcomes report on smoking and health actions, highlighting evidence on youth e-cigarette use and dispelling myths.

The New Nicotine Alliance has welcomed the new Smoking and Health Action Plan briefing, stating that it directly addresses the issue of youth vaping. The briefing was released last week and the New Nicotine Alliance referred to it as "a timely document, given the constant media attention on the topic in recent weeks.


The New Nicotine Alliance has announced that its briefing on smoking and health has been endorsed by several public health organizations. The briefing objectively reviews current regulations and the latest evidence from surveys on youth e-cigarette use.


The most important aspect is that it exposes many of the myths recently seen in the media, which have negatively distorted public perception of electronic cigarette products. The New Nicotine Alliance further added that "the UK is globally leading in recognizing the benefits of reduced-risk products like e-cigarettes in helping smokers quit, and we are pleased that ASH has responded to recent negative news with calm and balanced evidenced-based arguments.


A disposable e-cigarette contains less nicotine than a pack of 20 cigarettes. In comparison, a standard 2ml disposable e-cigarette in the UK contains 40mg of nicotine, whereas the average pack of 20 cigarettes contains 250mg of nicotine.


Most young people who try vaping are unlikely to become addicted to nicotine. Vapers are much less likely to develop dependence compared to smokers.


Electronic cigarettes have been on sale in the UK for 15 years, and have been the most popular smoking cessation aid since 2013. During this time, there has been no association between electronic cigarettes and the prevalent health issues in the UK.


In 2019, a severe respiratory illness outbreak (known as "EVALI") in the United States was determined to be caused by vaping marijuana laced with vitamin E acetate, not by nicotine inhalation.


The New Nicotine Alliance continued to state that "ASH emphasized how anti-vaping campaigns have distorted the truth in the minds of the public, contrasting this with the clear information provided in New Zealand versus the destructive approach taken in the US, which has led some young people to conclude that they'd rather smoke than switch to vaping. While it's regrettable that irresponsible media coverage should make such truth-telling necessary, we warmly welcome ASH's intervention and hope that local authorities and other organizations take note of this. In many other countries, moral panic about youth vaping has led to an erosion of controls over nicotine products, such that the benefits that smokers derive from switching to vaping have been entirely diminished or eradicated by restrictions and bans.


The New Nicotine Alliance continued to state, "We are pleased to see that the UK's public health organization has responded to clarify the facts with common sense and rationality, and to support the world's leading UK regulatory body in acknowledging that electronic cigarettes are an important means of helping smokers quit or significantly reducing their harm.


Statement


This article was compiled from third-party information and is intended for industry exchange and learning purposes only.


This article does not represent the views of 2FIRSTS and 2FIRSTS cannot confirm the authenticity and accuracy of the content of the article. The translation of this article is only for industry communication and research purposes.


Due to limitations in translation ability, this article may not fully reflect the original content. Please refer to the original text for accuracy.


2FIRSTS holds the same stance and position as the Chinese government on any domestic, Hong Kong, Macau, Taiwan, and foreign-related issues.


The compilation of information is owned by the original media source and author. If there is any infringement, please contact us for removal.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

AP Questions FDA Rationale as Glas Fruit-Flavored Vapes Won Authorization Without Added Cessation Benefit
AP Questions FDA Rationale as Glas Fruit-Flavored Vapes Won Authorization Without Added Cessation Benefit
The U.S. Food and Drug Administration (FDA) recently authorized two fruit-flavored vaping products from Glas, but a newly released agency memo shows the products did not demonstrate greater smoking-cessation benefits than tobacco-flavored e-cigarettes. The Associated Press said the findings are likely to raise further questions about the FDA’s regulatory rationale and standards for flavored vaping products.
Jun.12
One Nation Proposes 50% Tobacco Excise Cut as Australia’s Illicit Market Expands
One Nation Proposes 50% Tobacco Excise Cut as Australia’s Illicit Market Expands
Australian One Nation leader Pauline Hanson has proposed cutting tobacco excise by 50% and freezing indexation until June 30, 2028, in a bid to lower legal cigarette prices and reduce the price advantage of the illicit tobacco market.
Jun.18
 BAT Bangladesh Cigarette Sales Fall 14%, Q1 Profit Drops 34%
BAT Bangladesh Cigarette Sales Fall 14%, Q1 Profit Drops 34%
British American Tobacco Bangladesh reported a 14% year-on-year decline in cigarette sales volume and a 34% drop in first-quarter profit, highlighting mounting pressure from inflation, taxation, and weakening consumer spending in Bangladesh.
News
May.18
NielsenIQ and Goldman Sachs Data Show Smokeless Was the Only Growing Major U.S. Nicotine Category
NielsenIQ and Goldman Sachs Data Show Smokeless Was the Only Growing Major U.S. Nicotine Category
NielsenIQ and Goldman Sachs data show U.S. smokeless nicotine product sales rose more than 8% year over year in the 52 weeks ended May 30, making it the only major nicotine category to record growth.
Market
Jun.23
Malaysia Police Plan Saliva Tests at Roadblocks to Detect Synthetic Drugs Mixed Into Vape Liquids
Malaysia Police Plan Saliva Tests at Roadblocks to Detect Synthetic Drugs Mixed Into Vape Liquids
Malaysian police plan to use saliva test kits at roadblocks to detect drivers using synthetic liquid drugs marketed as “Piu Piu” and “Magic Mushroom,” substances that authorities say are mixed into vape liquids and inhaled through e-cigarette devices, raising road-safety concerns and adding pressure on vape regulation.
Jun.29
Illicit Vape and Nicotine Pouch Seizures Concentrated in UK Hotspots, New Data Shows
Illicit Vape and Nicotine Pouch Seizures Concentrated in UK Hotspots, New Data Shows
Freedom of Information (FOI) data from the UK shows that more than 3,000 seizures of illegal nicotine products were recorded in the 2024/25 financial year, with Hull, Liverpool and Bolton emerging as the most active enforcement hotspots — highlighting that the problem of illicit vapes, nicotine pouches and smokeless tobacco products persists across many parts of the country.
Jun.16